PTC Therapeutics, Inc. announced that on June 7, 2018 it approved non-statutory stock options to purchase an aggregate of 134,450 shares of its common stock to 18 new employees and a restricted stock unit for 3,000 shares of its common stock to one of the new employees.
June 8, 2018
· 2 min read